Results 1 to 10 of about 477,848 (284)

Post-COVID-19 neurocandidiasis [PDF]

Neurological Sciences, 2021
Associated with a significant morbidity and mortality, neurocandidiasis affects severely immunocompromised patients, especially if recently treated with antibiotics or corticosteroids. We present the case of a 70-year-old man admitted to an intensive care unit due to a Sars-Cov-2 pneumonia, with fever, coma, and multifocal neurological deficits ...
Miguel A. Miranda, Sandra C. Sousa, Vera L. Montes   +2 more
openaire   +6 more sources

Muscle Abnormalities in Nonhospitalised Patients With Post–COVID‐19 Condition [PDF]

Journal of Cachexia, Sarcopenia and Muscle
Background Post‐COVID condition (PCC) affects ~10% of SARS‐CoV‐2–infected individuals and manifests as persistent symptoms such as fatigue, exercise intolerance and muscle weakness.
Andrea Tryfonos, Gustav Jörnåker, Håkan Rundqvist, Kaveh Pourhamidi, Michael Melin, Helena Wallin, Filip J. Larsen, Spyridon Pantelios, Anders P. Mutvei, Veronika Tillander, Uwe J. F. Tietge, Sergio Perez Diaz, Douglas Crafoord, Alen Lovric, Rodrigo Fernandez‐Gonzalo, Eric Rullman, Per Stål, Thomas Gustafsson, Helene Rundqvist, Tommy R. Lundberg   +19 more
doaj   +2 more sources

Post-COVID-19 Syndrome

Nursing Research, 2022
Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, many individuals have reported persistent symptoms and/or complications lasting beyond 4 weeks, which is now called post-COVID-19 syndrome.
Janet D. Pierce, Qiuhua Shen, Samantha A. Cintron, John B. Hiebert   +3 more
  +9 more sources

COVID-19 vaccine safety monitoring in the Republic of Korea: February 26, 2021 to April 30, 2021 [PDF]

Osong Public Health and Research Perspectives, 2021
Objectives On February 26, 2021, coronavirus disease 2019 (COVID-19) vaccination was started for high-priority groups based on the recommendation of the Advisory Committee on Immunization Practices with 2 available COVID-19 vaccines (AstraZeneca and ...
Hyun-kyung Oh, Eun Kyeong Kim, Insob Hwang, Tae Eun Kim, Yeon-kyeong Lee, Eunju Lee, Yeon-Kyeng Lee   +6 more
doaj   +1 more source

COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021 [PDF]

Osong Public Health and Research Perspectives, 2021
Objectives This study aimed to present data on reported adverse events following coronavirus disease 2019 (COVID-19) vaccination in Republic of Korea from February 26 to October 31, 2021, and to determine whether any significant patterns emerged from an ...
Insob Hwang, Kyeongeun Park, Tae Eun Kim, Yunhyung Kwon, Yeon-Kyeng Lee   +4 more
doaj   +1 more source

Post-COVID-19 encephalomyelitis [PDF]

Neurological Research and Practice, 2021
AbstractSince the outbreak of coronavirus disease 2019 (COVID-19), a growing number of cases of acute transverse myelitis associated with COVID-19 have been reported. Here, we present the case of a patient who developed sensory ataxia after COVID-19 with MR lesions suggestive for longitudinal myelitis and in the splenium of the corpus callosum.
Kim, Ji-Won, Abdullayev, Nuran, Neuneier, Janina, Fink, Gereon R., Lehmann, Helmar C.   +4 more
openaire   +4 more sources

Modeling, post COVID-19 [PDF]

Science, 2020
Much of the public first learned about epidemiological modeling during the early months of the coronavirus disease 2019 (COVID-19) pandemic. The first models resulted in more confusion than clarity. Even though coronavirus cases were rising exponentially in the United States and Europe, some models predicted a rapid peak followed by a rapid decline ...
Press, William H., Levin, Richard C.
openaire   +2 more sources

Post-COVID-19 Condition

Annual Review of Medicine, 2023
An estimated 10–15% of those infected with SARS-CoV-2 may have post-COVID-19 condition. Common lingering signs and symptoms include shortness of breath, fatigue, high heart rate, and memory and cognitive dysfunction even several months after infection, often impacting survivors’ quality of life.
Ani, Nalbandian, Amar D, Desai, Elaine Y, Wan   +2 more
openaire   +2 more sources

Post-COVID-19

Modern Issues of Medicine and Management, 2023
After recovery from the coronavirus, there is a post-COVID period that lasts for 12 or more weeks. The degree of severity of the coronavirus infection directly affects the severity of subsequent symptoms of the disease. In addition to damage to the respiratory system and internal organs, the COVID-19 virus is also characterized by disruption of the ...
Aftab Ahmad, Vidushi Rathi, Prerna, Ravindra Nath, Pranav Ish   +4 more
  +5 more sources

Post COVID-19 MSSA pneumonia [PDF]

SAGE Open Medical Case Reports, 2021
Coronavirus disease 2019 (COVID-19) was first identified at the end of 2019 as a cluster of pneumonia cases in Wuhan, China. By February 2020, this virus quickly spread, becoming a global pandemic. The spectrum of symptomatic infection severity can range from mild, severe, and critical disease. Many correlated comorbidities were established, including
Bilal Chaudhry, Kirill Alekseyev, Lidiya Didenko, Andrew Malek, Gennadiy Ryklin   +4 more
openaire   +3 more sources